Intermediate metabolism in normal pregnancy and in gestational diabetes

被引:288
作者
Di Cianni, G
Miccoli, R
Volpe, L
Lencioni, C
Del Prato, S
机构
[1] Univ Pisa, Sect Diabet, Dept Endocrinol & Metab, I-56124 Pisa, Italy
[2] Azienda Ospedaleira Pisana, Diabet & Metabiol Dis Unit, Pisa, Italy
关键词
carbohydrate; lipid; metabolism; pregnancy; gestational diabetes mellitus;
D O I
10.1002/dmrr.390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Complex though integrated hormonal and metabolic changes characterize pregnancy. in the face of progressive decline in insulin action, glucose homeostasis is maintained through a compensatory increase in insulin secretion. This switches energy production from carbohydrates to lipids, making glucose readily available to the fetus. This precise and entangled hormonal and metabolic condition can, however, be disrupted and diabetic hyperglycemia can develop (gestational diabetes). The increase in plasma glucose level is believed to confer significant risk of complications to both the mother and the fetus and the newborn. Moreover, exposition of fetal tissues to the diabetic maternal environment can translate into an increased risk for development of diabetes and/or the metabolic syndrome in the adult life. in women with previous gestational diabetes, the risk of developing type 2 diabetes is greatly enhanced, to the point that GDM represents an early stage in the natural history of type 2 diabetes. In these women, accurate follow-up and prevention strategies are needed to reduce the subsequent development of overt diabetes. This paper will review current knowledge on the modifications occurring in normal pregnancy, while outlining the mechanisms. In this paper, we will review the changes of intermediary metabolism occurring during pregnancy. In particular, we will outline the mechanisms responsible for gestational diabetes; the link between these alterations and associated maternal and neonatal morbidity will be examined. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:259 / 270
页数:12
相关论文
共 128 条
[1]   IMPACT OF MATERNAL EUGLYCEMIA ON FETAL OUTCOME IN DIABETIC PREGNANCY [J].
ADASHI, EY ;
PINTO, H ;
TYSON, JE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 133 (03) :268-274
[2]  
Alvarez JJ, 1996, J LIPID RES, V37, P299
[3]   ADIPOCYTE INSULIN-RECEPTOR BINDING AND LIPOGENESIS AT TERM IN NORMAL-PREGNANCY [J].
ANDERSEN, O ;
KUHL, C .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (06) :575-581
[4]   Insulin resistance in type 2 diabetes: role of fatty acids [J].
Arner, P .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 :S5-S9
[5]  
Bartha JL, 2000, J REPROD MED, V45, P185
[6]   QUANTITATIVE ESTIMATION OF INSULIN SENSITIVITY [J].
BERGMAN, RN ;
IDER, YZ ;
BOWDEN, CR ;
COBELLI, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 236 (06) :E667-E677
[7]  
Berkowitz R, 1996, DIABETES, V45, P1572
[8]  
Bowes SB, 1996, DIABETOLOGIA, V39, P976
[9]   EFFECT OF HOMOLOGOUS PLACENTAL LACTOGENS, PROLACTINS, AND GROWTH-HORMONES ON ISLET B-CELL DIVISION AND INSULIN-SECRETION IN RAT, MOUSE, AND HUMAN ISLETS - IMPLICATION FOR PLACENTAL-LACTOGEN REGULATION OF ISLET FUNCTION DURING PREGNANCY [J].
BRELJE, TC ;
SCHARP, DW ;
LACY, PE ;
OGREN, L ;
TALAMANTES, F ;
ROBERTSON, M ;
FRIESEN, HG ;
SORENSON, RL .
ENDOCRINOLOGY, 1993, 132 (02) :879-887
[10]   EFFECT OF PROLACTIN VERSUS GROWTH-HORMONE ON ISLET FUNCTION AND THE IMPORTANCE OF USING HOMOLOGOUS MAMMOSOMATOTROPIC HORMONES [J].
BRELJE, TC ;
ALLAIRE, P ;
HEGRE, O ;
SORENSON, RL .
ENDOCRINOLOGY, 1989, 125 (05) :2392-2399